T 0509

Drug Profile

T 0509

Latest Information Update: 08 Aug 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Tanabe Seiyaku
  • Class Cardiotonics
  • Mechanism of Action Beta 1 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Heart failure; Ischaemic heart disorders

Most Recent Events

  • 02 Jul 1997 A study has been added to the Heart failure pharmacodynamics section
  • 12 Apr 1996 A preclinical study was added to the heart failure pharmacodynamics section .
  • 06 Jun 1995 A study in rats has been added to the heart failure pharmacodynamic section .
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top